0 143

Cited 0 times in

First-line pembrolizumab plus chemotherapy versus chemotherapy in advanced esophageal cancer: Longer-term efficacy, safety, and quality-oflife results from the phase 3 KEYNOTE-590 study

DC Field Value Language
dc.contributor.author조병철-
dc.date.accessioned2023-06-02T00:54:41Z-
dc.date.available2023-06-02T00:54:41Z-
dc.date.issued2022-02-
dc.identifier.issn0732-183X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194523-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherAmerican Society of Clinical Oncology-
dc.relation.isPartOfJOURNAL OF CLINICAL ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleFirst-line pembrolizumab plus chemotherapy versus chemotherapy in advanced esophageal cancer: Longer-term efficacy, safety, and quality-oflife results from the phase 3 KEYNOTE-590 study-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorJean-Philippe Metges-
dc.contributor.googleauthorKen Kato-
dc.contributor.googleauthorJong-Mu Sun-
dc.contributor.googleauthorManish A. Shah-
dc.contributor.googleauthorPeter C. Enzinger-
dc.contributor.googleauthorAntoine Adenis-
dc.contributor.googleauthorToshihiko Doi-
dc.contributor.googleauthorTakashi Kojima-
dc.contributor.googleauthorZhigang Li-
dc.contributor.googleauthorSung-Bae Kim-
dc.contributor.googleauthorByoung Chul Cho-
dc.contributor.googleauthorWasat Mansoor-
dc.contributor.googleauthorShau-Hsuan Li-
dc.contributor.googleauthorPatrapim Sunpaweravong-
dc.contributor.googleauthorMARIA ALSINA-
dc.contributor.googleauthorGary L Buchschacher-
dc.contributor.googleauthorJimin Wu-
dc.contributor.googleauthorSukrut Shah-
dc.contributor.googleauthorPooja Bhagia-
dc.contributor.googleauthorLin Shen-
dc.identifier.doi10.1200/JCO.2022.40.4_suppl.241-
dc.contributor.localIdA03822-
dc.relation.journalcodeJ01331-
dc.identifier.eissn1527-7755-
dc.identifier.urlhttps://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.241-
dc.contributor.alternativeNameCho, Byoung Chul-
dc.contributor.affiliatedAuthor조병철-
dc.citation.volume40-
dc.citation.number4 suppl-
dc.citation.startPage241-
dc.identifier.bibliographicCitationJOURNAL OF CLINICAL ONCOLOGY, Vol.40(4 suppl) : 241, 2022-02-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.